Stock News - bioAffinity Technologies, Inc. $BIAFW
Latest Stock News for $BIAFW
bioAffinity Technologies Reports 146% Growth in CyPath Lung Diagnostic Sales in Q1 2026
Expected Stock impact: Very Positive
2026-04-01 20:25:31
bioAffinity Technologies, Inc. Files 8-K with Presentation Materials on March 26, 2026
Expected Stock impact: None Expected
2026-03-26 12:02:41
bioAffinity Technologies to Host Virtual Roundtable on CyPath® Lung Use in Clinical Practice
Expected Stock impact: Slightly Positive
2026-03-25 20:38:07
bioAffinity Technologies Announces New Clinical Case Study for CyPath® Lung Test
Expected Stock impact: Noticeably Positive
2026-03-17 20:33:36
bioAffinity Technologies Reports Record Revenue and Unit Sales for CyPath® Lung in 2025
Expected Stock impact: Noticeably Positive
2026-03-13 12:32:27
